Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00326885
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2006-05-15
Brief Title:
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-15
First Submit QC Date:
May 15 2006
Study First Post Date:
2006-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-12-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-18
Last Update Post Date:
2018-10-17
Last Update Post Date Type:
ACTUAL